Trademark: 97241251
Status Date
Tuesday, March 14, 2023
Registration Number
7002127
Registration Date
Tuesday, March 14, 2023
Filing Date
Thursday, January 27, 2022
Published for Opposition
Tuesday, July 26, 2022
42 Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research services; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development, and pharmacogenetics; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services in the field of cancer; Pharmaceutical research and development; Product research and development; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical testing services and information in the field of cancer research and disease classification; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Mar 14, 2023
Notice Of Registration Confirmation Emailed
Mar 14, 2023
Registered-Principal Register
Feb 7, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Feb 6, 2023
Allowed Principal Register - Sou Accepted
Jan 9, 2023
Statement Of Use Processing Complete
Jan 4, 2023
Use Amendment Filed
Jan 4, 2023
Teas Statement Of Use Received
Oct 13, 2022
Corrected Noa E-Mailed
Oct 12, 2022
Notice Of Allowance Correction Entered
Oct 12, 2022
Case Assigned To Intent To Use Paralegal
Sep 23, 2022
Teas Post Publication Amendment Received
Sep 20, 2022
Noa E-Mailed - Sou Required From Applicant
Jul 26, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 26, 2022
Published For Opposition
Jul 6, 2022
Notification Of Notice Of Publication E-Mailed
Jun 23, 2022
Approved For Pub - Principal Register
Jun 2, 2022
Teas/Email Correspondence Entered
Jun 2, 2022
Correspondence Received In Law Office
Jun 2, 2022
Teas Response To Office Action Received
May 11, 2022
Notification Of Non-Final Action E-Mailed
May 11, 2022
Non-Final Action E-Mailed
May 11, 2022
Non-Final Action Written
May 9, 2022
Assigned To Examiner
Feb 1, 2022
New Application Office Supplied Data Entered
Jan 31, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
